(Q34260708)

1 August 2017

title

Morbidity and mortality in adult polymyositis and dermatomyositis (English)

1 reference

1 August 2017

0 references

0 references

Isabelle Marie

1

1 reference

1 August 2017

language of work or name

1 reference

1 June 2012

1 reference

Current Rheumatology Reports

1 August 2017

published in

1 reference

1 August 2017

volume

14

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

275-285

1 reference

Therapy of polymyositis and dermatomyositis

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Polymyositis and dermatomyositis (first of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Polymyositis and dermatomyositis (second of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Immunotherapy of myositis: issues, concerns and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Prognosis and mortality of polymyositis and dermatomyositis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Long-term outcome in polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Polymyositis: its presentation, morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Mortality from polymyositis and dermatomyositis in the United States, 1968-1978.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Adult-onset inflammatory myopathy: North Canterbury experience 1989-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Clinical characteristics and outcomes of patients with idiopathic inflammatory myopathies from Jordan 1996-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Survival, mortality and causes of death in inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Staphylococcal infections in childhood dermatomyositis--association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Population based intervention to change back pain beliefs and disability: three part evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Infectious Complications in Polymyositis and Dermatomyositis: A Series of 279 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: A series of 73 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

A novel autoantibody to a 155-kd protein is associated with dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0249-3

Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.

21 January 2018

1 reference

12 December 2020

Outcome of patients having dermatomyositis admitted to the intensive care unit

1 reference

12 December 2020

Cardiac manifestations in polymyositis/dermatomyositis: how to get to heart of the matter

1 reference

12 December 2020

Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy

1 reference

12 December 2020

Distinctive features of idiopathic inflammatory myopathies in French Canadians

1 reference

12 December 2020

Polymyositis--treatment and prognosis. A study of 107 patients

1 reference

12 December 2020

Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis

1 reference

12 December 2020

Comparison of clinical course of polymyositis and dermatomyositis: a follow-up study in Tokushima University Hospital

1 reference

12 December 2020

Hematological malignancy associated with polymyositis and dermatomyositis

1 reference

12 December 2020

Factors affecting survivorship in polymyositis. A life-table study of 124 patients

1 reference

12 December 2020

Periarticular calcinosis associated with anti-Jo-1 antibodies sine myositis. Expanding the clinical spectrum of the antisynthetase syndrome

1 reference

12 December 2020

Pulmonary involvement in polymyositis and in dermatomyositis

1 reference

12 December 2020

Opportunistic infections in polymyositis and dermatomyositis

1 reference

12 December 2020

Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis

1 reference

12 December 2020

Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-dermatomyositis

1 reference

12 December 2020

Survival in polymyositis: corticosteroids and risk factors

1 reference

12 December 2020

A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups

1 reference

12 December 2020

Interstitial lung disease in polymyositis and dermatomyositis

1 reference

12 December 2020

Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients

1 reference

12 December 2020

Dermatomyositis with multiple skin ulcers showing vasculitis and membrano-cystic lesion

1 reference

12 December 2020

1 reference

12 December 2020

A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis

1 reference

12 December 2020

Influence of age on characteristics of polymyositis and dermatomyositis in adults

1 reference

12 December 2020

Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis

1 reference

12 December 2020

Periarticular calcifications and arthropathy as the first manifestation of polymyositis

1 reference

12 December 2020

Long-term prognosis of 69 patients with dermatomyositis or polymyositis

1 reference

12 December 2020

Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality

1 reference

12 December 2020

10.1007/S11926-012-0249-3

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1016486166

0 references

1 reference